Peer Review reports
From: A phase I study of imatinib, dacarbazine, and capecitabine in advanced endocrine cancers
Original Submission | ||
---|---|---|
6 Mar 2014 | Submitted | Original manuscript |
20 May 2014 | Reviewed | Reviewer Report - Jennifer Chan |
26 May 2014 | Reviewed | Reviewer Report - Michele Kim |
9 Jun 2014 | Author responded | Author comments - Daniel Halperin |
Resubmission - Version 2 | ||
9 Jun 2014 | Submitted | Manuscript version 2 |
17 Jun 2014 | Reviewed | Reviewer Report - Jennifer Chan |
2 Jul 2014 | Reviewed | Reviewer Report - Michele Kim |
16 Jul 2014 | Author responded | Author comments - Daniel Halperin |
Resubmission - Version 3 | ||
16 Jul 2014 | Submitted | Manuscript version 3 |
Publishing | ||
22 Jul 2014 | Editorially accepted | |
2 Aug 2014 | Article published | 10.1186/1471-2407-14-561 |
You can find further information about peer review here.